Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1997 Jul-Sep;3(3):371–372. doi: 10.3201/eid0303.970316

Emerging quinolone-resistant Salmonella in the United States.

H Herikstad 1, P Hayes 1, M Mokhtar 1, M L Fracaro 1, E J Threlfall 1, F J Angulo 1
PMCID: PMC2627645  PMID: 9284384

Abstract

We conducted a national survey of antimicrobial resistance in human clinical isolates of Salmonella between July 1, 1994, and June 30, 1995. Every tenth nontyphoidal Salmonella isolate received at state public health laboratories in the United States during this period was tested for resistance to 12 antimicrobial agents, including two quinolones, nalidixic acid, and ciprofloxacin. Emerging quinolone resistance was detected; of 4,008 isolates tested, 21 (0.5%) were resistant to nalidixic acid, and one (0.02%) was resistant to ciprofloxacin. Continued surveillance for quinolone-resistant Salmonella is necessary, particularly after the recent approval of a fluoroquinolone for use in animals intended for food in the United States.

Full Text

The Full Text of this article is available as a PDF (15.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Centers for Disease Control and Prevention (CDC) Establishment of a national surveillance program for antimicrobial resistance in Salmonella. MMWR Morb Mortal Wkly Rep. 1996 Feb 9;45(5):110–111. [PubMed] [Google Scholar]
  2. Cherubin C. E., Eng R. H. Quinolones for the treatment of infections due to Salmonella. Rev Infect Dis. 1991 Mar-Apr;13(2):343–344. doi: 10.1093/clinids/13.2.343. [DOI] [PubMed] [Google Scholar]
  3. Cohen M. L., Tauxe R. V. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science. 1986 Nov 21;234(4779):964–969. doi: 10.1126/science.3535069. [DOI] [PubMed] [Google Scholar]
  4. Frost J. A., Kelleher A., Rowe B. Increasing ciprofloxacin resistance in salmonellas in England and Wales 1991-1994. J Antimicrob Chemother. 1996 Jan;37(1):85–91. doi: 10.1093/jac/37.1.85. [DOI] [PubMed] [Google Scholar]
  5. Hof H., Ehrhard I., Tschäpe H. Presence of quinolone resistance in a strain of Salmonella typhimurium. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):747–749. doi: 10.1007/BF01972501. [DOI] [PubMed] [Google Scholar]
  6. Lee L. A., Puhr N. D., Maloney E. K., Bean N. H., Tauxe R. V. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis. 1994 Jul;170(1):128–134. doi: 10.1093/infdis/170.1.128. [DOI] [PubMed] [Google Scholar]
  7. Threlfall E. J., Frost J. A., Ward L. R., Rowe B. Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet. 1996 Apr 13;347(9007):1053–1054. doi: 10.1016/s0140-6736(96)90199-3. [DOI] [PubMed] [Google Scholar]
  8. Turnidge J. Epidemiology of quinolone resistance. Eastern hemisphere. Drugs. 1995;49 (Suppl 2):43–47. doi: 10.2165/00003495-199500492-00008. [DOI] [PubMed] [Google Scholar]
  9. Wilcox M. H., Spencer R. C. Quinolones and Salmonella gastroenteritis. J Antimicrob Chemother. 1992 Aug;30(2):221–228. doi: 10.1093/jac/30.2.221. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES